XERS
Xeris Pharmaceuticals Inc
9.10$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.9% | 97.9% | 98.2% | 80.3% | 80.3% | 46.9% | 54.2% | 48.4% | 51.9% | 62.7% | |
| 96.2% | 93.4% | 38.1% | 17.9% | 17.9% | 22.1% | 35.4% | 20.9% | 22.2% | 29.0% | |
| 96.2% | 93.4% | 93.8% | 69.3% | 69.3% | 33.7% | 35.4% | 22.5% | 22.2% | 29.0% | |
| 0.3% | 2.7% | 2.4% | 5.2% | 4.3% | 5.7% | 8.9% | 12.2% | 12.5% | 13.3% | |
| – | 0.0% | – | 2.0% | 2.0% | 6.0% | 7.2% | 12.0% | 14.9% | 17.9% | |
| 0.9% | 1.8% | 1.7% | 7.2% | 6.2% | 2.2% | 2.8% | – | – | – | |
| – | – | – | – | 0.0% | 7.5% | 6.6% | 7.1% | 7.1% | 6.0% | |
| – | – | – | – | – | 43.2% | 35.0% | 34.0% | 30.6% | 23.0% | |
| 195.2% | 228.5% | 37.2% | 86.8% | 86.8% | 68.7% | 86.9% | 102.1% | 109.2% | 96.4% | |
| 7.5% | 10.8% | 8.5% | 25.1% | 25.1% | 26.0% | 21.4% | 29.5% | 31.1% | 28.6% | |
| 2.7% | 5.7% | 6.8% | – | – | 0.5% | 0.5% | 1.1% | 6.6% | 1.6% | |
| 3.9% | 4.4% | 0.7% | 5.1% | 5.1% | 2.9% | 1.3% | 3.6% | 0.7% | 0.8% | |
| – | – | 26.6% | 53.5% | 79.8% | 28.9% | 54.3% | 59.2% | 67.2% | 57.4% | |
| -95.2% | -128.5% | 62.8% | 13.2% | 13.2% | 31.3% | 13.1% | -2.1% | -9.2% | 3.6% | |
| -101.5% | -134.6% | -100.5% | -225.9% | -225.9% | -151.2% | -161.0% | -191.3% | -208.0% | -175.0% | |
| 5.5% | 4.5% | 10.0% | 24.0% | 24.0% | 26.0% | 39.4% | 42.7% | 45.4% | 45.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.